The clinical role of interleukin-6 and interleukin-6 soluble receptor in human follicular fluids

2003 ◽  
Vol 3 (1) ◽  
pp. 27-31 ◽  
Author(s):  
F. Kawasaki ◽  
Y. Kawano ◽  
Z. Kosay Hasan ◽  
H. Narahara ◽  
I. Miyakawa
Keyword(s):  
Interleukin 6 ◽  
Soluble Receptor ◽  
Clinical Role ◽  
Follicular Fluids

scholarly journals Role of different dialysis membranes in the release of interleukin-6-soluble receptor in uremic patients

2000 ◽  
Vol 58 (1) ◽  
pp. 417-424 ◽  
Author(s):  
Bruno Memoli ◽  
Loredana Postiglione ◽  
Bruno Cianciaruso ◽  
Vincenzo Bisesti ◽  
Cristina Cimmaruta ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Soluble Receptor ◽  
Dialysis Membranes ◽  
Uremic Patients

scholarly journals 317 Aldosterone and interleukin-6: the synergic effect in COVID-19

2021 ◽  
Vol 23 (Supplement_G) ◽  
Author(s):  
Pasquale Campana ◽  
Maria Emiliana Palaia ◽  
Maddalena Conte ◽  
Laura Petraglia ◽  
Lorenzo Ferrante ◽  
...  
Keyword(s):  
Interleukin 6 ◽  
Ventricular Dysfunction ◽  
Adrenal Adenoma ◽  
Severe Pneumonia ◽  
Serum Levels ◽  
High Serum ◽  
Mineralocorticoid Receptors ◽  
Soluble Receptor ◽  
Severe Hypoxaemia

Abstract Aims Several evidence have identified the role of Interleukin-6 (IL-6) in the cytokine storm induced by COVID-19. Interestingly, the correlation between the serum levels of IL-6 and the plasma aldosterone has already been demonstrated in patients affected by primary aldosteronism (PA). Thus, we suppose that hyperaldosteronism may increase IL-6 levels in COVID-19. Methods and results We report a case of 47-year-old female Covid-19 patient who had developed severe pneumonia complicated by Guillain–Barreé syndrome (GBS). Blood test revealed high levels of IL-6 (serum IL-6: 402 pg/ml) and of its soluble receptor (soluble IL-6 receptor >1900 pg/ml) and she required mechanical ventilation for severe hypoxaemia. Furthermore, the evidence of right adrenal adenoma, resistant hypertension, severe hypokalaemia, and high serum levels of aldosterone with high aldosterone/renin ratio were also consistent with diagnosis of PA. Thus, Spironolactone was administered with rapid improvements in clinical condition. Finally, she was diagnosed with acute motor sensitive neuropathy and started the rehabilitation phase. Conclusions Elevated aldosterone levels in PA may stimulate IL-6 production, inducing more severe forms of COVID-19 with the development of serious complications such as GBS. Hyperaldosteronism may also contribute to the poorest prognosis of patients with secondary aldosteronism such as heart failure and COVID-19, in which elevated IL-6 levels could exert its detrimental effects, mostly on the progression of ventricular dysfunction. Further studies are necessary to evaluate therapy with mineralocorticoid receptors antagonists such as spironolactone in COVID-19.

Comments on expanding the clinical role of psychologists.

1996 ◽  
Vol 51 (3) ◽  
pp. 216-218 ◽  
Author(s):  
Rachel G. Klein
Keyword(s):  
Clinical Role

Role of interleukin-6 in the early and late fracture healing phase

2016 ◽  
Author(s):  
Katja Prystaz ◽  
Anna Kovtun ◽  
Kathrin Kaiser ◽  
Verena Heidler ◽  
Jochen Kroner ◽  
...  
Keyword(s):  
Fracture Healing ◽  
Interleukin 6 ◽  
Healing Phase
Sign in / Sign up

Export Citation Format

Share Document